HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marketing in Brief: Ultima II

This article was originally published in The Rose Sheet

Executive Summary

Ultima II: CHR Double Action products "firm the skin and smooth away fine, dry lines," according to Ultima II. The three new CHR items -- Double Action day lotion, night cream and eye cream -- contain dehydrated micro-collagen spheres to "plump up fine, dry lines, fill in imperfections" and provide a "firming moisture lift," the Revlon division said. Extensine, a patented, plant-derived ingredient, "layers the skin with a flexible moisturizing film to smooth, tighten and texturize," the company added. Enriched with ceramides, the SPF 15 day lotion "recharges the skin with a moisture lift, builds firmness and boosts resilience," the company said. The night cream employs salicylic acid to "slough off" dull surface cells, while the eye cream "increases the resilience and elasticity" of the eye area, Ultima II said. On-counter in February, the 2 oz. day lotion and 2 oz. night cream will be priced at $35 and $45, respectively. The .5 eye cream will cost $27.50...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS003545

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel